Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. - Wikidata - wikimedia - TriplyDB

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

http://www.wikidata.org/entity/Q35792134

about

Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.Promoter methylation of E-cadherin in hepatocellular carcinomas and dysplastic nodules DNA methylation: potential biomarker in Hepatocellular Carcinoma.Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.Effects of dual modified resistant indica rice starch on azoxymethane-induced incipient colon cancer in mice.DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.Epigenetic targets of bioactive dietary components for cancer prevention and therapy.Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.Epigenetic silencing of glutaminase 2 in human liver and colon cancers.P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.Hepatitis B virus infection and the risk of hepatocellular carcinoma.Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.DNA methyltransferase 3b silencing affects locus-specific DNA methylation and inhibits proliferation, migration and invasion in human hepatocellular carcinoma SMMC-7721 and BEL-7402 cells.DNA markers in molecular diagnostics for hepatocellular carcinoma.Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

P2860

Q26851211-562566D6-5336-4CB9-95F4-12EBB026DF4C Q27003050-FC4CEB62-F880-403D-B156-C7527E642318 Q27023744-AB156A3A-5E93-4A08-937A-125D888B4543 Q28383720-F1CF377D-33D1-4401-95D8-8B3E7B13143B Q28392002-5FAF80BB-9D55-443F-A424-1111E39C7E31 Q28567487-C9E7803B-7E62-48DD-9BA0-D326EB2C4DC9 Q28730441-AAECF4BC-2E42-4A1D-B9DB-655827941C5A Q28743228-AD4AC994-B826-4F95-A160-4A3044610D3D Q30405398-25743872-C4E7-4BC5-81C2-7D5FC6B80297 Q33543795-97CB06C6-EE02-4246-926E-25CD5D06CF80 Q33559593-3650F0AC-416B-471D-BEC3-098A7E26D875 Q33599535-1ACC966B-C5E1-47E3-9608-0D013F587787 Q33617129-4664EEC8-AB2D-46BD-8ADC-F66AEF9BD7FF Q33714992-E494887A-4E49-427C-8329-D7D4E5F92B05 Q33724001-8595E9EE-5319-4D1A-9E2D-D6435FC4714D Q33766987-F3E983CF-8AE6-471F-B435-20C59F037606 Q33793560-4A58F863-2873-4DB3-A5C1-6A124250A1F5 Q33831996-B6029290-31DF-42D7-A080-0601F606CD4E Q33847115-C8192127-ED3E-4179-950A-2D8C0EC4147C Q33907989-93FBA37B-A82D-4BB1-AE76-AFE5BA373303 Q34004801-EEFBBECE-8FCA-46DB-B187-B99AB4B63FE9 Q34004837-B7188E8F-42DC-481A-AE6F-0260ACDA96E2 Q34168643-FB3CE141-9342-409F-B3F9-B3CB79B5127B Q34268708-CD0441E4-4C85-4EB0-83E0-2F8137B8C3D7 Q34344549-FF396BC0-2DB4-4BE4-A212-7C5FAD727F22 Q34401887-D96FF770-01CB-45E8-A9A1-A60121CEA0CC Q34508252-E1759CF9-60A2-4229-A9D0-DA1D89416C0A Q34681945-95C5938A-0307-496C-A80E-4ADB04E6B31A Q35065476-39D6C1B2-924C-4782-B8F9-272006228604 Q35093637-8460F272-DA05-4127-82B3-EC1F6A4E34F8 Q35197356-9B317068-9846-4B00-9CA1-54CFCEFB5381 Q35589600-04770D2F-2A6E-4DA2-974E-373467A09491 Q35606904-7ECBD07C-A9C6-4901-BE2B-BB25B1670D56 Q35615943-1A2092D6-EA6C-48FD-ADFE-9FDABC3E7ADE Q35699313-7183922D-A42D-4BDD-877B-A90C79DC0E1E Q35758190-AE48A22B-5744-4F8C-82A1-96ED6E896609 Q35781255-0AD3C820-2E06-4E45-AF75-506EC0E86739 Q35793705-C81C69F6-73BF-4506-AB82-1D5ADA064F85 Q35804238-9E890FD3-B8B5-4BB2-8766-D140EE146361 Q35945177-67751682-6C08-4A3B-89A4-BE2D789B3849

P2860

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

http://www.wikidata.org/entity/Q35792134

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@ast

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@en

type

label

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@ast

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@en

prefLabel

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@ast

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@en

P1433

Q35792134-A6861EE9-90E6-40DC-A42B-7662A9880B96

P1476

Q35792134-A0BACC67-B263-4250-8525-4562E8125469

P2093

Q35792134-0B6B8AEC-88B3-41DF-B8CB-C287BC9F2E24

Q35792134-0FE709E4-0EEE-42B9-8A07-330FB4FE37E5

Q35792134-92A72655-A6FD-4C06-B5E0-F2C7BAB17D11

Q35792134-9860EFB8-D139-4F86-86CC-5E44897DF6DC

Q35792134-C1EFBA5E-8389-404C-99CB-A2D676A27EFD

Q35792134-C276F3C4-57FC-4262-B86D-0518B182AF66

P2860

Q35792134-0281646C-F120-4DDC-87DD-51A68A6603D4

Q35792134-0D444F9E-4991-4059-A238-A461B5B597E0

Q35792134-1104FE33-6F66-4D44-BF18-B80078D211CA

Q35792134-19C87680-D188-4137-9510-2ACEFEC0B989

Q35792134-216AE478-DF2D-4466-B235-74ABA403F783

Q35792134-29C9DB9F-84B2-4EDC-BEA2-B97390D983B2

Q35792134-2C614093-6F87-4652-AE43-93515A811704

Q35792134-3120C21E-4C2D-40CF-94E8-2127A889FF4D

Q35792134-4F3D0365-92E9-4598-AF4A-73EADDE07F9A

Q35792134-6209BAC4-06CC-48DA-9185-E35B46F5E214

P304

Q35792134-81DF5833-6AA9-4B54-AFBD-F51DE73E087C

P31

Q35792134-35E56907-C7E4-430B-8B40-D660BF254BBB

P356

Q35792134-EE68D5F6-CEB9-4CBE-AB32-8714E687ECEA

P407

Q35792134-1D98781F-5AE1-4E67-B1CE-D85EA454D7A6

P433

Q35792134-972E6BB0-6BF4-44EE-B8D0-11003E6A3FC4

P478

Q35792134-C250A354-B489-4627-8B5C-CD935507D543

P577

Q35792134-3BC9E428-EDD8-4C4A-AD1F-F9F9CF316753

P698

Q35792134-E4CC831A-097F-4888-AC2B-069EF1FE20FB

P932

Q35792134-C7E9DA71-6207-4A94-B43A-FD30B070DD5C

P356

S0002-9440(10)63495-5

P1433

The American Journal of Pathology

P1476

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

@en

P2093

Gyeong Hoon Kang

http://www.w3.org/2001/XMLSchema#string

Hyeon Joo Lee

http://www.w3.org/2001/XMLSchema#string

Hyo-Suk Lee

http://www.w3.org/2001/XMLSchema#string

Ja June Jang

http://www.w3.org/2001/XMLSchema#string

Jae-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Sun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Cancer epigenetics comes of age

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

Epidemiology of primary liver cancer.

DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression.

Chromosomal insertion of foreign (adenovirus type 12, plasmid, or bacteriophage lambda) DNA is associated with enhanced methylation of cellular DNA segments.

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

Genetic mechanisms of hepatocarcinogenesis.

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

P304

1371-1378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63495-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14507645

http://www.w3.org/2001/XMLSchema#string

P932

1868296

http://www.w3.org/2001/XMLSchema#string